BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 17343232)

  • 1. [Different approaches for medical or surgical management of Crohn's disease: the importance of the classification of Vienna].
    Colombo PL; Benedetti M; Tinozzi FP; Ticozzelli E; Maroni N; Di Sabatino A; Tinozzi S
    Ann Ital Chir; 2006; 77(6):485-96. PubMed ID: 17343232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is it time to re-classify Crohn's disease?
    Fedorak RN
    Best Pract Res Clin Gastroenterol; 2004; 18 Suppl():99-106. PubMed ID: 15588801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indications for laparoscopic surgery for Crohn's disease using the Vienna Classification.
    Okabayashi K; Hasegawa H; Watanabe M; Nishibori H; Ishii Y; Hibi T; Kitajima M
    Colorectal Dis; 2007 Nov; 9(9):825-9. PubMed ID: 17645573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Vienna classification of Crohn's disease: helpful or dispensable? A critical view].
    Leiss O; Börner N
    Z Gastroenterol; 2007 Mar; 45(3):265-72. PubMed ID: 17357958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypes defined by the "Vienna Classification" in 100 Hungarian patients with Crohn's disease.
    Nemetz A; Molnar T; Zagoni T; Kovacs A; Tulassay Z; Nagy F; Salvador Peña A
    Rev Esp Enferm Dig; 2003 Aug; 95(8):533-8, 527-33. PubMed ID: 14514338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of anti-Saccharomyces cerevisiae antibody (ASCA) in Korean patients with Crohn's disease and its relationship to the disease clinical course.
    Kim BC; Park S; Han J; Kim JH; Kim TI; Kim WH
    Dig Liver Dis; 2007 Jul; 39(7):610-6. PubMed ID: 17531556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease.
    Louis E; Collard A; Oger AF; Degroote E; Aboul Nasr El Yafi FA; Belaiche J
    Gut; 2001 Dec; 49(6):777-82. PubMed ID: 11709511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunomodulators are associated with a lower risk of first surgery among patients with non-penetrating non-stricturing Crohn's disease.
    Picco MF; Zubiaurre I; Adluni M; Cangemi JR; Shelton D
    Am J Gastroenterol; 2009 Nov; 104(11):2754-9. PubMed ID: 19584832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does cigarette smoking influence the phenotype of Crohn's disease? Analysis using the Montreal classification.
    Aldhous MC; Drummond HE; Anderson N; Smith LA; Arnott ID; Satsangi J
    Am J Gastroenterol; 2007 Mar; 102(3):577-88. PubMed ID: 17338736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical therapy for refractory pediatric Crohn's disease.
    Faubion WA; Bousvaros A
    Clin Gastroenterol Hepatol; 2006 Oct; 4(10):1199-213. PubMed ID: 16872913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The phenotype and clinical patterns of Crohn's disease in the Chinese].
    Wu X; Lu XH
    Zhonghua Nei Ke Za Zhi; 2006 Aug; 45(8):661-3. PubMed ID: 17074153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of clinical behaviour in Crohn's disease: predictive factors of penetrating complications.
    Papi C; Festa V; Fagnani C; Stazi A; Antonelli G; Moretti A; Koch M; Capurso L
    Dig Liver Dis; 2005 Apr; 37(4):247-53. PubMed ID: 15788208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
    Henriksen M; Jahnsen J; Lygren I; Stray N; Sauar J; Vatn MH; Moum B;
    Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Crohn's disease: influence of age at diagnosis on clinical type of disease].
    Elloumi H; Sfar S; Ben Abdelaziz A; Arfaoui D; Mouna G; Ajmi S
    Tunis Med; 2007 Oct; 85(10):862-5. PubMed ID: 18236809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical perspectives in Crohn's disease. Serologic and prognostic biomarkers: who, when, and how?
    Dubinsky MC
    Rev Gastroenterol Disord; 2007; 7 Suppl 2():S3-7. PubMed ID: 17392637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term partial remission of autoimmune thrombocytopenia in a patient treated with the anti-tumor necrosis factor-alpha antibody infliximab for refractory fistulizing Crohn's disease.
    de Rossi TM; Krauss N; Voll RE; Nägel A; Weidenhiller M; Konturek PC; Hahn EG; Raithel M
    Digestion; 2008; 78(4):195-200. PubMed ID: 19122456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes of Crohn's disease phenotype over time.
    Ouaz A; Fekih M; Labidi A; Ben Mustapha N; Serghini M; Zouiten L; Boubaker J; Filali A
    Tunis Med; 2016 Jun; 94(6):167-170. PubMed ID: 28051217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural history of pediatric Crohn's disease: a population-based cohort study.
    Vernier-Massouille G; Balde M; Salleron J; Turck D; Dupas JL; Mouterde O; Merle V; Salomez JL; Branche J; Marti R; Lerebours E; Cortot A; Gower-Rousseau C; Colombel JF
    Gastroenterology; 2008 Oct; 135(4):1106-13. PubMed ID: 18692056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recurrence of Crohn's disease after surgery--causes and risks].
    Mirow L; Hauenschild L; Hildebrand P; Kleemann M; Keller R; Franke C; Roblick UJ; Bruch HP; Kujath P
    Zentralbl Chir; 2008 Apr; 133(2):182-7. PubMed ID: 18415909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Azathioprine for prevention of postoperative recurrence in Crohn's disease].
    Abdelli MN; Ben Abdallah H; Houissa F; Bouali MR; Khediri MF
    Tunis Med; 2007 Jul; 85(7):569-72. PubMed ID: 18064988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.